News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
797,756 Results
Type
Article (59818)
Company Profile (341)
Press Release (737579)
Multimedia
Podcasts (173)
Webinars (26)
Section
Business (216961)
Career Advice (2982)
Deals (37628)
Drug Delivery (162)
Drug Development (85597)
Employer Resources (191)
FDA (17716)
Job Trends (16367)
News (368887)
Policy (36321)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3007)
Academic (2)
Accelerated approval (54)
Adcomms (34)
Allergies (188)
Alliances (53039)
ALS (230)
Alzheimer's disease (1936)
Antibody-drug conjugate (ADC) (527)
Approvals (18082)
Artificial intelligence (772)
Autoimmune disease (338)
Automation (61)
Bankruptcy (381)
Best Places to Work (12511)
BIOSECURE Act (22)
Biosimilars (242)
Biotechnology (205)
Bladder cancer (204)
Brain cancer (79)
Breast cancer (824)
Cancer (6391)
Cardiovascular disease (527)
Career advice (2531)
Career pathing (52)
CAR-T (369)
CDC (74)
Celiac Disease (3)
Cell therapy (1000)
Cervical cancer (52)
Clinical research (74171)
Collaboration (2288)
Company closure (6)
Compensation (1481)
Complete response letters (96)
COVID-19 (3011)
CRISPR (122)
C-suite (1257)
Cystic fibrosis (164)
Data (8524)
Decentralized trials (3)
Denatured (49)
Depression (182)
Dermatology (96)
Diabetes (648)
Diagnostics (7513)
Digital health (65)
Diversity (14)
Diversity, equity & inclusion (47)
Drug discovery (363)
Drug pricing (237)
Drug shortages (34)
Duchenne muscular dystrophy (308)
Earnings (95393)
Editorial (77)
Employer branding (23)
Employer resources (167)
Events (131772)
Executive appointments (1181)
FDA (21702)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (36)
Funding (1886)
Gene editing (261)
Generative AI (72)
Gene therapy (802)
GLP-1 (1209)
Government (5456)
Grass and pollen (7)
Guidances (418)
Healthcare (21069)
HIV (90)
Huntington's disease (59)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (111)
Immunology and inflammation (331)
Immuno-oncology (109)
Indications (200)
Infectious disease (3401)
Inflammatory bowel disease (232)
Inflation Reduction Act (17)
Influenza (146)
Intellectual property (312)
Interviews (538)
IPO (17368)
IRA (56)
Job creations (4185)
Job search strategy (2084)
JPM (70)
Kidney cancer (22)
Labor market (113)
Layoffs (644)
Leadership (52)
Legal (8839)
Liver cancer (108)
Longevity (35)
Lung cancer (851)
Lymphoma (458)
Machine learning (63)
Management (65)
Manufacturing (1155)
MASH (217)
Medical device (15015)
Medtech (15164)
Mergers & acquisitions (21552)
Metabolic disorders (1700)
mRNA (257)
Multiple sclerosis (200)
NASH (21)
Neurodegenerative disease (483)
Neuropsychiatric disorders (118)
Neuroscience (3611)
Neurotech (1)
NextGen: Class of 2026 (7343)
Non-profit (5101)
Now hiring (80)
Obesity (806)
Opinion (370)
Ovarian cancer (238)
Pain (276)
Pancreatic cancer (342)
Parkinson's disease (404)
Partnered (34)
Patents (631)
Patient recruitment (730)
Peanut (68)
People (63818)
Pharmaceutical (73)
Pharmacy benefit managers (36)
Phase 1 (23158)
Phase 2 (32498)
Phase 3 (24271)
Pipeline (9532)
Policy (379)
Postmarket research (2910)
Preclinical (9941)
Press Release (71)
Prostate cancer (336)
Psychedelics (65)
Radiopharmaceuticals (367)
Rare diseases (1200)
Real estate (6554)
Recruiting (77)
Regulatory (27952)
Reports (61)
Research institute (2722)
Resumes & cover letters (482)
Rett syndrome (40)
RNA editing (25)
RSV (97)
Schizophrenia (191)
Series A (320)
Series B (231)
Service/supplier (13)
Sickle cell disease (126)
Special edition (32)
Spinal muscular atrophy (180)
Sponsored (54)
Startups (4011)
State (2)
Stomach cancer (21)
Supply chain (140)
Tariffs (101)
The Weekly (121)
Vaccines (1271)
Venture capital (125)
Weight loss (544)
Women's health (137)
Worklife (24)
Date
Last 7 days (758)
Last 30 days (3169)
Last 365 days (31953)
2026 (15211)
2025 (31980)
2024 (37132)
2023 (42217)
2022 (53574)
2021 (58259)
2020 (57209)
2019 (50754)
2018 (38572)
2017 (34921)
2016 (35067)
2015 (40985)
2014 (34573)
2013 (29961)
2012 (32118)
2011 (32837)
2010 (30864)
Location
Africa (998)
Alabama (99)
Alaska (7)
Arizona (380)
Arkansas (15)
Asia (45275)
Australia (7551)
California (14090)
Canada (3924)
China (1513)
Colorado (602)
Connecticut (626)
Delaware (433)
Europe (100139)
Florida (2090)
Georgia (463)
Hawaii (4)
Idaho (69)
Illinois (1176)
India (98)
Indiana (654)
Iowa (24)
Japan (581)
Kansas (139)
Kentucky (55)
Louisiana (47)
Maine (89)
Maryland (1714)
Massachusetts (10259)
Michigan (400)
Minnesota (783)
Mississippi (7)
Missouri (162)
Montana (37)
Nebraska (29)
Nevada (151)
New Hampshire (92)
New Jersey (3754)
New Mexico (34)
New York (3707)
North Carolina (1868)
North Dakota (11)
Northern California (7066)
Ohio (433)
Oklahoma (26)
Oregon (47)
Pennsylvania (2794)
Puerto Rico (29)
Rhode Island (52)
South America (1359)
South Carolina (88)
South Dakota (2)
Southern California (5578)
Tennessee (221)
Texas (2272)
United States (50262)
Utah (424)
Vermont (1)
Virginia (355)
Washington D.C. (86)
Washington State (1138)
West Virginia (4)
Wisconsin (150)
Wyoming (2)
797,756 Results for "more health inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cancer
ASCO: A battle of bispecifics, Eli Lilly’s big win and more
Practice-changing data in lung cancer, prostate cancer and more were on display over the weekend at the American Society of Clinical Oncology annual meeting in Chicago. Plus, early readouts on assets that could reshape the cancer landscape.
June 1, 2026
·
4 min read
·
Brianna Abbott
Podcast
ASCO wins from RevMed, Akeso/Summit, more; plus more Lilly and more China; ADA on deck
Improved survival on display at the American Society of Clinical Oncology (ASCO) in Chicago; Pfizer’s unusual pact with China’s Innovent highlights a new type of collaboration; Eli Lilly continues its nonstop deal streak, including with Chinese biotechs; and looking ahead to this weekend’s American Diabetes Association meeting.
June 3, 2026
·
2 min read
·
Jef Akst
Press Releases
Progyny, Inc. to Present at BofA Securities 2026 Health Care Conference
May 11, 2026
·
1 min read
Press Releases
DaVita Inc. to Participate in the BofA Securities 2026 Health Care Conference
May 7, 2026
·
1 min read
Press Releases
Novartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030
April 9, 2026
·
7 min read
Mergers & acquisitions
Pharma’s M&A Train Is on Track for Record Highs With More Deals To Come: Analysts
After a flurry of deals over the past week from Eli Lilly, Merck and Biogen, analysts predict more M&A action from other big names, including Novartis, Amgen and AbbVie.
April 3, 2026
·
3 min read
·
Annalee Armstrong
Podcast
Pfizer, Lilly, more report Q1, FDA names acting CBER director and an ALS awakening
First quarter earnings continue to arrive, with analysts demanding more from cautious Pfizer and Eli Lilly expecting more revenue; the FDA taps Katherine Szarama as Vinay Prasad’s controversial FDA tenure ends; oncology veterans miss Richard Pazdur at the agency’s first adcomm in nine months; and QurAlis and Corcept Therapeutics spark renewed hope in ALS.
May 6, 2026
·
1 min read
·
Heather McKenzie
Sponsored
Turn health data into impact: Browns University’s online master in biostatistics & health data science
Trained biostatisticians play a central role in clinical science and public health. Brown’s online master’s in biostatistics (health data science concentration), prepares you with a strong foundation in biostatistical and data science methods combined with rigorous training in applied skills to make critical data-driven decisions and meet the growing demand for leaders in this industry – on your schedule
April 27, 2026
·
3 min read
Obesity
Boehringer, Zealand’s obesity drug ‘more akin’ to Novo’s Wegovy in Phase 3
Topline Phase 3 results of survodutide—licensed to Boehringer Ingelheim from Zealand Pharma—are more comparable to Novo Nordisk’s Wegovy than to Eli Lilly’s Zepbound, William Blair analysts said on Tuesday.
April 28, 2026
·
2 min read
·
Heather McKenzie
Drug pricing
Trump’s MFN Pricing Expected To Delay More European Drug Launches
Following Insmed’s decision to hold off on launching a newly approved lung disease drug in Europe, experts anticipate more companies will do the same as they seek to avoid price erosion in the U.S. Will Chinese biotechs fill the void?
April 1, 2026
·
3 min read
·
Nick Paul Taylor
1 of 79,776
Next